Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertrophic Cardiomyopathy Symptom Relief by Midodrine
2015-003521-34Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hypertrophic cardiomyopathy (HCM) comparing Midodrine with Placebo (2 arms). Primary endpoint: 6-minute walk test distance at Day 15. Started Sep 2015; status: active.
02
Drugs
midodrine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2015-003521-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003521-34.